List of Pepcid Ac drug patents
Pepcid Ac is owned by J And J Consumer Inc.
Pepcid Ac contains Famotidine.
Pepcid Ac has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Pepcid Ac are:
- US6814978*PED
Pepcid Ac was authorised for market use on 24 September, 1998.
Pepcid Ac is available in tablet, chewable;oral dosage forms.
The generics of Pepcid Ac are possible to be released after 26 February, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6814978 (Pediatric) | J AND J CONSUMER INC | Process for preparing a soft tablet |
Feb, 2022
(1 year, 3 months ago) | |
Do you want to check out PEPCID AC patents from before 2022?
Drugs and Companies using FAMOTIDINE ingredient
Market Authorisation Date: 24 September, 1998
Treatment: NA
Dosage: TABLET, CHEWABLE;ORAL
How can I launch a generic of PEPCID AC before it's patent expiration?
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic